Kelonia Therapeutics, Inc.

About Kelonia

Clinical-stage biotechnology company developing in vivo CAR-T cell therapies using proprietary iGPS gene placement system. Lead program KLN-1010 in Phase 1 for relapsed/refractory multiple myeloma.
Get insights on Kelonia
with chemXplore Alpha

About Kelonia on our platform

To provide comprehensive coverage, we aggregate data and news under the name Kelonia, encompassing the following company names, divisions, and related entities:

Kelonia Therapeutics.

This list encompasses current and former names, alternate names, and key divisions associated with Kelonia, ensuring you can easily find all relevant information under a single, unified profile.